Health Conditions

Immunexpress – Near-Patient Diagnostic For Sepsis – SeptiCyte® RAPID

Immunexpress---Near-Patient-Diagnostic-For-Sepsis---SeptiCyte®-RAPID

Dr. Rollie Carlson, CEO of Immunexpress discusses the development and commercialization plans for SeptiCyte® RAPID.  SeptiCyte® RAPID is a test that quantifies the immune response to infection and will provide actionable results in about one hour to guide physicians when making patient management decisions.

Frequently Asked Questions

What is the main topic discussed in this episode of Health Professional Radio?

This episode covers important developments in healthcare, including updates on Healthcare. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.

How can healthcare professionals benefit from this information?

Healthcare professionals can stay informed about the latest developments in Healthcare and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.

Where can I find more information about Healthcare?

For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.

Rolland (Rollie) Carlson, Ph.D. is CEO at Immunexpress, a molecular diagnostic company committed to improving outcomes for patients suspected of sepsis. Dr. Carlson has over 25 years’ experience in business and new product development, global commercial and general management in biotechnology. Previously, he served as President and CEO of WaferGen Biosystems. Prior to WaferGen, Dr. Carlson was President and CEO of Asuragen, a privately-held molecular diagnostic company. Earlier in his career, over a 20-year period, he held increasingly senior positions at Abbott Laboratories, including Vice President and General Manager of the Vysis molecular diagnostic business following its acquisition. Dr. Carlson graduated with Ph.D. in Botany and Plant Physiology from Southern Illinois University and was a post-doctoral research fellow at the Harbor Branch Oceanographic Research Institute in Florida.

Last updated: June 22, 2020

Medical Disclaimer

The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.